What matters in prostate cancer treatment is not simply removing the cancer. How much urinary and sexual function can be ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted radiotherapies with the potential to transform cancer treatment, today announced ...

A prostate cancer diagnosis can leave men weighing several consequential decisions, from active surveillance and regular monitoring to surgery and radiation therapy.

Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An ...

Breakthrough prostate cancer research has been published in Nature. Research conducted at the Fred Hutch Cancer Center has ...

First-in-human Phase 1 presentation to feature ATNM-400 clinical data in metastatic castration-resistant prostate cancer, advancing a differentiated approach beyond PSMA Preclinical presentation to ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one agent shown to shrink tumors in patients whose disease had resisted every ...

University of East Anglia researchers have discovered the genetic blueprints of 18 new bacterial species collected from ...

Surgery Mode in Unfold AI brings patient-specific 3D maps to give an enhanced view of cancer anatomy during robotic prostate ...

Researchers at the Medical University of Vienna found a specialized imaging test detected 91% of prostate cancer cases in a ...

A UK Biobank analysis associated GDF15, TNC, TNFRSF10B and RRM2 with all-cause mortality among 353 men with prostate cancer, ...